Clinical trial
Schedules of Nab-Paclitaxel in Metastatic Breast Cancer
NCT01746225 · ETOP IBCSG Partners Foundation, Other · Completed
Key facts
| NCT number | NCT01746225 |
|---|---|
| Title | Schedules of Nab-Paclitaxel in Metastatic Breast Cancer |
| Official title | A Randomized Phase II Study Evaluating Different Schedules of Nab-Paclitaxel in Metastatic Breast Cancer (SNAP Trial) |
| Acronym | SNAP |
| Lead sponsor | ETOP IBCSG Partners Foundation, Other |
| Collaborators | Breast International Group |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Breastcancer |
| Intervention type | Drug |
| Interventions | nab-Paclitaxel |
| Enrollment | 258 |
| Start date | Apr 1, 2013 |
| Primary completion | May 1, 2016 |
| Completion | Mar 16, 2023 |
| First posted | Dec 10, 2012 |
| Last update posted | Jun 1, 2023 |
| Countries | Belgium, Ireland, Italy, Slovenia, Spain, Switzerland |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: